Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Null Results in Brief

Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry

Shengfeng Wang, Yonglan Zheng, Temidayo O. Ogundiran, Oladosu Ojengbede, Wei Zheng, Katherine L. Nathanson, Barbara Nemesure, Stefan Ambs, Olufunmilayo I. Olopade and Dezheng Huo
Shengfeng Wang
1Department of Epidemiology & Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.
2Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yonglan Zheng
2Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Temidayo O. Ogundiran
3Department of Surgery, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oladosu Ojengbede
4Center for Population and Reproductive Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Zheng
5Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine L. Nathanson
6Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Nemesure
7Department of Preventive Medicine, State University of New York at Stony Brook, Stony Brook, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Ambs
8Laboratory of Human Carcinogenesis, NCI, Bethesda, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olufunmilayo I. Olopade
2Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhuo@health.bsd.uchicago.edu folopade@bsd.uchicago.edu
Dezheng Huo
2Center for Clinical Cancer Genetics and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois.
9Department of Public Health Sciences, University of Chicago, Chicago, Illinois.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dhuo@health.bsd.uchicago.edu folopade@bsd.uchicago.edu
DOI: 10.1158/1055-9965.EPI-17-0755 Published January 2018
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Pancreatic cancer mutation signatures closely resemble breast cancer, suggesting that both cancers may have common predisposition mechanisms that may include commonly inherited SNPs.

Methods: We examined 23 genetic variants known to be associated with pancreatic cancer as breast cancer risk factors in the Root genome-wide association study (GWAS; 1,657 cases and 2,029 controls of African diaspora) and GAME-ON/DRIVE GWAS (16,003 cases and 41,335 controls of European ancestry).

Results: None of the pancreatic cancer susceptibility variants were individually associated with breast cancer risk after adjustment for multiple testing (at α = 0.002) in the two populations. In Root GWAS, a change by one SD in the polygenic risk score (PRS) was not significantly associated with breast cancer. In addition, we did not observe a trend in the relationship between PRS percentiles and breast cancer risk.

Conclusions: The association between reported pancreatic cancer genetic susceptibility variants and breast cancer development in women of African or European ancestry is likely weak, if it does exist.

Impact: Known GWAS-derived susceptibility variants of pancreatic cancer do not explain its shared genetic etiology with breast cancer. Cancer Epidemiol Biomarkers Prev; 27(1); 116–8. ©2017 AACR.

Introduction

Patients with pancreatic cancer have been found to carry rare germline deleterious variants in breast cancer susceptibility genes, such as BRCA1, BRCA2, PALB2, and ATM (1–3). In addition, a number of common SNPs were identified to be associated with common diseases, including pancreatic and breast cancers, by hypothesis-free genome-wide association study (GWAS) approach. Couch and colleagues evaluated the SNPs associated with breast cancer risk for influence on pancreatic cancer risk and found the SNP rs1045485 retained significance after adjusting for multiple testing (4). Furthermore, an interesting phenomenon indicated in the Catalogue of Somatic Mutations in Cancer was that the 7 mutational signatures of pancreatic cancer were all shared by those of breast cancer (http://cancer.sanger.ac.uk/signatures/matrix.png). These lines of evidence suggest that breast cancer and pancreatic cancer might have common predisposition mechanisms.

To date, many of the common variants associated with the risk of pancreatic cancer have been identified by the GWAS approach, and more than 20 loci reached the standard GWAS significance threshold (5), but no study has explored the possible associations between these SNPs and breast cancer risk. Here, we examined whether GWAS-identified genetic susceptibility to pancreatic cancer is related to breast cancer risk using GWAS datasets from two breast cancer consortia: Root and GAME-ON/DRIVE.

Materials and Methods

The Root consortium contained 1,657 cases and 2,029 controls of African diaspora, in which genotyping was conducted using the Illumina HumanOmni2.5-8v1 array, and imputation was conducted with the 1000 Genomes Project Phase 1 as reference panel (6). The GAME-ON/DRIVE GWAS is a meta-analysis of 12 breast cancer GWAS, including 16,003 cases and 41,335 controls of European ancestry (http://gameon.dfci.harvard.edu). Both studies were conducted in accordance of U.S. common rule, have been approved by their institutional review board, and obtained informed written consent from all the participants (6).

A total of 23 known independent pancreatic cancer susceptibility loci (P < 5 × 10−8) were extracted from the NHGRI-EBI GWAS Catalog (https://www.ebi.ac.uk/gwas/, accessed on January 14, 2017). For Root GWAS, we used logistic regression with case status as the outcome and an additive model for genotype, adjusting for age (10-year groups), study site, and the first four eigenvectors from principal component analysis. For GAME-ON/DRIVE GWAS, fixed-effects meta-analysis was used and the SEs were adjusted by the inflation factors. We also constructed a polygenic risk score (PRS) based on risk allele frequencies across all loci and evaluated its relation to breast cancer risk in Root. The PRS was calculated as the log OR-weighted sum of risk allele counts, defined as Embedded Image, where Embedded Image is the number of risk alleles carried by an individual at the ith SNP with Embedded Image and Embedded Image is the per-allele OR associated with the ith SNP. Adjusted ORs and 95% confidence intervals (CI) were used to measure the association of breast cancer risk with genetic variants or PRS. Statistical significance was declared at the 0.0022 (0.05/23) level for each SNP.

Results

For women of African ancestry, rs31490-G was a risk allele in both pancreatic and breast cancers, whereas the risk allele rs401681-T in pancreatic cancer became a protective allele in breast cancer (Table 1). Similarly, for women of European ancestry, rs11655237-T and rs2736098-C were found to be risk alleles in both pancreatic and breast cancers, but two pancreatic cancer risk alleles rs505922-C and rs687289-A turned to be protective for breast cancer (Table 1). The aforementioned SNPs were nominal significantly association with breast cancer risk; however, none of them remained significant after the adjustment for multiple testing.

View this table:
  • View inline
  • View popup
Table 1.

Association of pancreatic cancer susceptibility variants with risk of breast cancer

For Root GWAS, one SD change [0.571] in the PRS was not significantly associated with breast cancer. The ORs for developing breast cancer by percentiles of the PRS, relative to women in the middle quintile, showed no linear trend (Table 2). The discriminative accuracy of the pancreatic cancer PRS, as measured by the C-statistic, was 0.508 (95% CI, 0.489–0.526) for breast cancer.

View this table:
  • View inline
  • View popup
Table 2.

Performance of PRS based on pancreatic cancer susceptibility variants in the GWAS of breast cancer in the African diaspora

Discussion

We found that known GWAS risk variants for pancreatic cancer do not have a significant association with breast cancer risk among women of African or European ancestry. It is also worth noting that the direction in the associations for half of the nominal significant SNPs was not consistent with those observed in the pancreatic cancer studies that identified these SNPs as risk factors (Table 1). Our result is consistent with a recently published study using cancer-specific GWAS summary statistics data based on subjects of European ancestry, which did not find significant genetic correlations between pancreatic and breast cancer (genetic correlation coefficient = 0.17, P = 0.37; ref. 7). In conclusion, the association between known GWAS-identified pancreatic cancer susceptibility variants and breast cancer risk is likely weak in women of African or European ancestry, if it does exist.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Authors' Contributions

Conception and design: S. Wang, Y. Zheng

Development of methodology: S. Wang

Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): Y. Zheng, T.O. Ogundiran, O. Ojengbede, W. Zheng, K.L. Nathanson, B. Nemesure, S. Ambs, D. Huo

Analysis and interpretation of data (e.g., statistical analysis, biostatistics, computational analysis): S. Wang, Y. Zheng, D. Huo

Writing, review, and/or revision of the manuscript: S. Wang, Y. Zheng, T.O. Ogundiran, O. Ojengbede, W. Zheng, K.L. Nathanson, B. Nemesure, S. Ambs, O.I. Olopade, D. Huo

Administrative, technical, or material support (i.e., reporting or organizing data, constructing databases): O. Ojengbede

Study supervision: O. Ojengbede, O.I. Olopade, D. Huo

Acknowledgments

O.I. Olopade received the following grants: NCI CA089085, CA142996, and CA161032; Susan G. Komen for the Cure SAC110026; American Cancer Society CRP-10-119-01-CCE; Ralph and Marion Falk Medical Research Trust; Breast Cancer Research Foundation; and Avon Foundation. D. Huo received American Cancer Society MRSG-13-063-01-TBG, Breast Cancer Research Foundation, and NCI CA161032. S. Ambs received NCI intramural grant ZIA BC 010887.

The authors thank all the women who participated in this research.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • Received August 15, 2017.
  • Revision received November 9, 2017.
  • Accepted November 13, 2017.
  • ©2017 American Association for Cancer Research.

References

  1. 1.↵
    1. Mocci E,
    2. Milne RL,
    3. Mendez-Villamil EY,
    4. Hopper JL,
    5. John EM,
    6. Andrulis IL,
    7. et al.
    Risk of pancreatic cancer in breast cancer families from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 2013;22:803–11.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Jones S,
    2. Hruban RH,
    3. Kamiyama M,
    4. Borges M,
    5. Zhang X,
    6. Parsons DW,
    7. et al.
    Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009;324:217.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Roberts NJ,
    2. Jiao Y,
    3. Yu J,
    4. Kopelovich L,
    5. Petersen GM,
    6. Bondy ML,
    7. et al.
    ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2012;2:41–6.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Couch FJ,
    2. Wang X,
    3. McWilliams RR,
    4. Bamlet WR,
    5. de Andrade M,
    6. Petersen GM
    . Association of breast cancer susceptibility variants with risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3044–8.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. MacArthur J,
    2. Bowler E,
    3. Cerezo M,
    4. Gil L,
    5. Hall P,
    6. Hastings E,
    7. et al.
    The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res 2017;45:D896–D901.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Huo D,
    2. Feng Y,
    3. Haddad S,
    4. Zheng Y,
    5. Yao S,
    6. Han YJ,
    7. et al.
    Genome-wide association studies in women of African ancestry identified 3q26.21 as a novel susceptibility locus for estrogen receptor negative breast cancer. Hum Mol Genet 2016;25:4835–46.
    OpenUrl
  7. 7.↵
    1. Lindstrom S,
    2. Finucane H,
    3. Bulik-Sullivan B,
    4. Schumacher FR,
    5. Amos CI,
    6. Hung RJ,
    7. et al.
    Quantifying the genetic correlation between multiple cancer types. Cancer Epidemiol Biomarkers Prev 2017;26:1427–35.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 27 (1)
January 2018
Volume 27, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry
Shengfeng Wang, Yonglan Zheng, Temidayo O. Ogundiran, Oladosu Ojengbede, Wei Zheng, Katherine L. Nathanson, Barbara Nemesure, Stefan Ambs, Olufunmilayo I. Olopade and Dezheng Huo
Cancer Epidemiol Biomarkers Prev January 1 2018 (27) (1) 116-118; DOI: 10.1158/1055-9965.EPI-17-0755

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry
Shengfeng Wang, Yonglan Zheng, Temidayo O. Ogundiran, Oladosu Ojengbede, Wei Zheng, Katherine L. Nathanson, Barbara Nemesure, Stefan Ambs, Olufunmilayo I. Olopade and Dezheng Huo
Cancer Epidemiol Biomarkers Prev January 1 2018 (27) (1) 116-118; DOI: 10.1158/1055-9965.EPI-17-0755
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Diet Quality and Ovarian Cancer Survival
  • PDE5 inhibitors use and precursors of colorectal cancer
  • Association between serum iron biomarkers and breast cancer
Show more Null Results in Brief
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement